Revenue + Forward P/E
Elanco Animal Health Incorporated (ELAN) quarterly revenue and forward P/EForward P/E: 19.3x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$11.29B
Enterprise value
$16.21B
P/E ratio (TTM)
-50.86x
P/S ratio (TTM)
2.58x
P/B ratio
1.94x
EV/Sales
3.31x
EV/EBITDA
21.22x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$4.71B
Gross profit (TTM)
$2.05B
Operating income (TTM)
$252.00M
EBITDA (TTM)
$676.00M
Net income (TTM)
$-232.00M
Free cash flow (TTM)
$284.00M
Margins & returns
Gross margin
49.44%
Operating margin
8.95%
Profit margin
-4.95%
Return on equity
-3.64%
Return on assets
-1.83%
Per-share metrics
EPS (TTM)
-$0.49
Dividend yield
0.00%
Beta
1.69
Capital structure
Cash & equivalents
$545.00M
Total debt
$4.02B
Net debt
$3.47B
Shares outstanding
499.45M
Financial health
Current ratio
2.17
Debt / equity
0.61
Debt / assets
0.30
Interest coverage
1.15
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $630.14B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $443.33B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.40B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.49B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $11.29B | -50.86x | 2.58x | 21.22x | - |